NASDAQ:GDRX - GoodRx Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $50.54
  • Forecasted Upside: 32.30 %
  • Number of Analysts: 13
  • Breakdown:
  • 1 Sell Ratings
  • 6 Hold Ratings
  • 6 Buy Ratings
  • 0 Strong Buy Ratings
$38.20
▼ -0.37 (-0.96%)
1 month | 3 months | 12 months
Get New GoodRx Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for GDRX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for GDRX

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$50.54
▲ +32.30% Upside Potential
This price target is based on 13 analysts offering 12 month price targets for GoodRx in the last 3 months. The average price target is $50.54, with a high forecast of $70.00 and a low forecast of $29.00. The average price target represents a 32.30% upside from the last price of $38.20.
Hold
The current consensus among 13 polled investment analysts is to hold stock in GoodRx.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/8/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/6/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/5/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/4/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/2/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/31/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 6 hold ratings
  • 1 sell ratings
10/30/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 6 hold ratings
  • 1 sell ratings
11/29/2020

Latest Recommendations

  • 0 strong buy ratings
  • 6 buy ratings
  • 6 hold ratings
  • 1 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/23/2020The Goldman Sachs GroupLower Price TargetNeutral$49.00 ➝ $44.00Low
i
11/20/2020Credit Suisse GroupLower Price TargetOutperform$60.00 ➝ $49.00Low
i
11/19/2020BarclaysLower Price TargetEqual Weight$55.00 ➝ $35.00High
i
11/19/2020Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$56.00High
i
11/18/2020Morgan StanleyDowngradeOverweight ➝ Equal Weight$36.00Low
i
11/18/2020JPMorgan Chase & Co.Reiterated RatingNeutral ➝ Underweight$29.00Low
i
Rating by Doug Anmuth at JPMorgan Chase & Co.
11/18/2020Deutsche Bank AktiengesellschaftLower Price TargetHold$50.00 ➝ $31.00High
i
11/17/2020JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$29.00High
i
10/19/2020The Goldman Sachs GroupInitiated CoverageNeutral$48.00High
i
10/19/2020CowenInitiated CoverageOutperform$63.00High
i
10/19/2020Morgan StanleyInitiated CoverageOverweight$57.00High
i
10/19/2020JPMorgan Chase & Co.Initiated CoverageNeutral$59.00High
i
10/19/2020Raymond JamesInitiated CoverageEqual Weight ➝ Market Perform$57.00 ➝ $61.00High
i
10/19/2020Credit Suisse GroupInitiated CoverageOutperform$60.00High
i
10/19/2020Deutsche Bank AktiengesellschaftInitiated CoverageHold$50.00High
i
10/19/2020Royal Bank of CanadaInitiated CoverageSector Perform$55.00High
i
10/19/2020Bank of AmericaInitiated CoverageNeutral$58.00High
i
10/19/2020UBS GroupInitiated CoverageBuy$64.00High
i
10/19/2020Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellInitiated CoverageBuy$70.00High
i
10/19/2020BarclaysInitiated CoverageEqual Weight$53.00High
i
10/19/2020SVB LeerinkInitiated CoverageOutperform$61.00High
i
Rating by S. Demko at SVB Leerink LLC
(Data available from 11/29/2015 forward)
GoodRx logo
GoodRx Holdings, Inc. is a holding company. The company, through its subsidiaries, owns and operates a prescription drug price comparison platform using data from local and mail-order pharmacies in the United States. It also provides pharmacy coupons to customers. The company offers generic and brand name pricing; alerts clients on manufacturer co-pay cards, pharmacy discounts, and state discount programs; and provides tips on slashing drug prices. It provides prices of drugs in areas of alcohol dependence, allergies, cold, Alzheimer's disease, angina, antibiotics, anticoagulant, antiviral, antiplatelet, anxiety, arrhythmia, arrhythmia, asthma, bipolar disorder, birth control, cancer, cerebral hemorrhage, cholesterol, COPD, depression, dermatology, diabetes, ear, enlarged prostate, epilepsy, eye, fertility, fibromyalgia, flu, gastrointestinal, heart failure, hypertension, hypotension, immune system, insomnia, medical supplies, men's health, mental health, migraine, myasthenia gravis, nausea, nervous system, obesity, obsessive-compulsive disorder, opioid dependence, pain relief, arthritis, panic disorder, Parkinson's disease, PMDD, restless leg syndrome, schizophrenia, seizure, sleep aids, smoking and addiction, smoking cessation, thyroid drugs, Tourette syndrome, trazodone, urology, vaccines, and women's health. GoodRx Holdings, Inc. was incorporated in 2015 and is based in Santa Monica, California.
Read More

Today's Range

Now: $38.20
$37.80
$39.38

50 Day Range

MA: $48.05
$33.76
$54.96

52 Week Range

Now: $38.20
$33.51
$64.22

Volume

1,366,087 shs

Average Volume

3,418,782 shs

Market Capitalization

$14.91 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A